5
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Case Reports

Pages 79-87 | Published online: 07 Aug 2009

References

  • Seinera P, Raspollini M, Privitera S, Farina C, Crana F. Bilateral ovarian leiomyoma. Acta Obstet Gynecol Scand 1997; 76: 488–9.
  • Beck RP, Loutour JP Review of 1019 benign ovarian neoplasms. Obstet Gynecol 1960; 16: 479–82.
  • Van Winter JT, Stanhope CR. Giant ovarian leiomyoma associated with ascites and polymyositis. Obstet Gynecol 1992; 80 (3, part 2): 560–3.
  • Khaffaf N, Khaffaf H, Wuketich S. Giant ovarian leiomyoma as a rare cause of acute abdomen and hydronephrosis. Obstet Gynecol 1996; 87: 872–3.
  • Aleksander T. Nonspecific tumors of the ovary, including mesenchymal tumors and malignant lymphoma. In: Kurman Robert J, ed. Blausteins’ pathology of the female genital tract. New York: 4th edn, 1994: 917–18.
  • Vierhout ME, Pijpers L, Ng A, Tham M, Chadha-Ajwani S. Leiomyoma of the ovary. Acta Obstet Gynecol Scand 1990; 69: 445–7.
  • Nicoll JJ, Cox PJ. Leiomyoma of the ovary with ascites and hydrothorax. Am J Obstet Gynecol 1989; 161: 177–8.
  • Carpen O, Simberg N, Sasano H, Saksela E. Virilizing ovarian leiomyoma: androgen production by lining stromal cells. Acta Obstet Gynecol Scand 1996; 75: 72–6.
  • Mallya S, MacFarlane IA, Taylor W, vanHeyningen C. Thecal cell reaction associated with an ovarian leiomyoma and presenting with virilization. Gynecol Endocrinol 1990; 4: 271–6.
  • Choudhuri PK, Mukherj AK. Leiomyoma of the ovary. Am J Obstet Gynecol 1972; 113: 1142–4.
  • Okamura H, Virutamasen P, Wright KH, Wallach EE. Ovarian smooth muscle in the human being, rabbit and cat. Am J Obstet Gynecol 1972; 112: 183–91.
  • Kleitsman RJ. Ein Beitrag zur Kenntnis der Leiomyoma des Ovariums. Acta Obstet Gynecol Scand 1950; 29: 161–74.
  • Lastarria D, Sachdev RK, Babury RA, Yu HM, Nuovo GJ. Immunohistochemical analysis for desmin in normal and neoplastic ovarian stromal tissue. Arch Pathol Lab Med 1990; 114: 502–5.
  • Scully RE. Smooth muscle differentiation in genital tract disorders. Arch Pathol Lab Med 1981; 105: 505–7.
  • Evans AJ, Viltshaw E, Kochaowski SJ, MacFarlane A, Securs RT. Metastasising leiomyoma of the uterus and hormonal manipulation. Case report. Br J Obstet Gynaecol 1986; 93: 646–8.
  • Prayson RA, Hart WR. Primary smooth-muscle tumors of the ovary. A clinico-pathologic study of four leiomyomas and two mitotically active leiomyomas. Arch Pathol Lab Med 1992; 116: 1068–71.
  • Perrone T, Dehner LP. Prognostically favorable ‘mitotically active’ smooth muscle tumors of the uterus: a clinicopathologic study of ten cases. Am J Surg Pathol 1988; 12: 1–8.
  • O’Connor DM, Norris HJ. Mitotically active leiomyomas of the uterus. Hum Pathol 1990; 21: 223–7.lactone for treatment of maternal Bartter s syndrome (letter). Am J Obstet Gynecol 1996; 174(1): 297.

References

  • Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med 1962; 33: 811–28.
  • Gordon JA, Stokes JB III. Understanding and treating Bartter Syndrome. Hosp Pract 1994 May: 103–10.
  • Rudin A. Bartter’s syndrome. A review of 28 patients followed for 10 years. Acta Med Scand 1988; 224: 165–71.
  • Almeida OD Jr, Spinnato JA. Maternal Bartter’s syndrome and pregnancy. Am J Obstet Gynecol l989; 160: 1225–6.
  • Groves TD, Corenblum B. Spironolactone therapy during human pregnancy (letter). Am J Obstet Gynecol 1995; 172(5): 1655–6.
  • Rigo J Jr, Glaz E, Papp Z. Low or high doses of spironolactone for treatment of maternal Bartter s syndrome (letter). Am J Obstet Gynecol 1996; 174(1): 297.

References

  • Clark SL. New concepts of amniotic fluid embolism: A review. Obstet Gynecol Surv 1990; 45: 360–8.
  • Jacobs MM, Knight AB, Arias F. Maternal pulmonary edema resulting from betamimetic and glucocorticoid therapy. Obstet Gynecol 1980; 56: 56–9.
  • Morgan M. Amniotic fluid embolism. Anaesthesia 1979; 34: 20–32.
  • Goodman LR, Lipchik RJ. Diagnosis of acute pulmonary embolism: Time for a new approach. Radiology 1996; 199: 25–7.
  • Clark SL, Pavlova Z, Greenspoon J, Horenstein J, Phelan JP Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol 1986; 154: 104.

References

  • Thompson CE, Damon LE Ries CA, Linker CA. Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 1992; 80: 1890–5.
  • Weiner CP Thrombotic microangiopathy in pregnancy and the postpartum period. Semin Hematol 1987; 24: 119–29.
  • Rose M, Rowe JM, Eldor A. The changing course of thrombotic thrombocytopenic purpura and modern therapy. Blood Rev 1993; 7; 94–103.
  • Ruggenenti P, Remuzzi G. The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 1996; 56: 191–207.
  • Martin JN, Stedman CM. Imitators of preeclampsia and HELLP syndrome. Obstet Gynecol Clin North Am 1991; 18: 181–98.
  • McCrae KR, Cines DB. Thrombotic microangiopathy during pregnancy. Semin Hematol 1997; 34: 148–58.
  • Dashe JS, Ramin SM, Cunningham FG. The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 1998; 91: 662–8.
  • Weiner CP, Brandt J. Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia-eclampsia. Am J Obstet Gynecol 1982; 142: 275–81.

References

  • Sainz Samitier R. ‘Tumores malignos del estómago’. In Farreras and Rozman’s Medicina Interna. Barcelona, Spain, Ediciones Doyma S.A., 1992: pp. 97–101.
  • Ueo H, Matsuoka H, Tamura S, Sato K, Tsunematsu Y, Kato T. Prognosis in gastric cancer associated with pregnancy. World J Surg 1991; 15: 293–8.
  • Mendoza R, Mandiola M, Aparicio V, Corcostegui B, Matorras R, Barrenetxea G et al. Cultivo múltiple de ovocitos humanos como metodo de mejora de la tasa de fertilizacion en FIV Rev Iberoam Fertil 1993; 10: 233–8.
  • Whittemore AS, Harris R, Itnyre J and the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial cancers in white women. Am J Epidemiol 1992; 136: 1175–83.
  • Harris R, Whitemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US casecontrol studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992; 136: 1204–11.
  • Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771–6.
  • Matorras R, Gutierrez de Terán G. Cáncer y tratamiento médico de la esterilidad. Progr Obstet Ginecol 1996; 39: 475–85.
  • Le MG, Bauchelot A, Hill C. Characteristics of reproductive life and risk of breast cancer in a case control study of young nulliparous women. J Clin Epidemiol 1989; 42: 1227–33.
  • Tokunaga A, Kojima N, Andoh T. Hormone receptors in gastric cancer. Eur J Clin Oncol 1983; 19: 687–9.
  • Theodoropoulos GE, Lazaris A, Panoussopoulos D, Davaris P, Golematis BC. Significance of Estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma. J Surg Oncol 1995; 58: 176–83.
  • Furukawa H, Iwanaga T, Koyama H. Effects of sex hormones on carcinogenesis in the stomach of rats. Cancer Res 1982; 42: 5181–2.
  • Maeta M, Yamashiro H, Oka A, Tsujitani S, Ikeguchi M, Kaibara N. Gastric cancer in the young, with special reference to 14 pregnancy-associated cases: analysis based on 2,325 consecutive cases of gastric cancer. J Surg Oncol 1995; 58: 191–5.
  • La Vecchia C, D’Avanzo B, Franceschi S, Negri E, Parazzini F, Decarli A. Menstrual and reproductive factors and gastric-cancer risk in women. Int J Cancer 1994; 59: 7614.
  • Wu CW, Chang YF, Yeh TH, Chang TJ, Lui WY, P’Eng FK et al. Steroid hormone receptors in three human gastric cancer cell lines. Dig Dis Sci 1994; 39: 2689–94.
  • Polimeno L, Silecchia G, Spaziani E, Scucchi A, Dell’Aquila P, Ierardi E et al. Estrogens, androgens, and EGF receptor expression in gastric carcinoma induced by N-methyl-N’-nitro-N-nitrosoguanidine. Dig Dis Sci 1994; 39: 635–40.
  • Furukawa H, Iwanaga T, Hiratsuka M, Imaoka S, Ishika-wa O, Kabuto T et al. Gastric cancer in young adults: growth accelerating effect of pregnancy and delivery. J Surg Oncol 1994; 55: 3–6.
  • Machado JC, Carneiro F, Gartner F, Ribeiro P, Sobrinho-Simoes M. Female sex hormone receptors are not involved in gastric carcinogenesis. A biochemical and immunohistochemical study. Eur J Cancer Prev 1994; 3 suppl 2: 31–7.
  • Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346: 995–1000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.